about
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...
Read More
10.56
-0.75
(-6.63%)
226.6K
XNAS Volume
XNAS 11 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Oculis Holding AG Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..